[1]魏艳丽.重症急性胰腺炎的治疗现状[J].医学信息,2021,34(19):55-57.[doi:10.3969/j.issn.1006-1959.2021.19.014]
 WEI Yan-li.Treatment Status of Severe Acute Pancreatitis[J].Medical Information,2021,34(19):55-57.[doi:10.3969/j.issn.1006-1959.2021.19.014]
点击复制

重症急性胰腺炎的治疗现状()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年19期
页码:
55-57
栏目:
综述
出版日期:
2021-10-01

文章信息/Info

Title:
Treatment Status of Severe Acute Pancreatitis
文章编号:
1006-1959(2021)19-0055-03
作者:
魏艳丽
天津市武清区中医医院肺病脾胃病科,天津 301700
Author(s):
WEI Yan-li
Department of lung, Spleen and Stomach,Wuqing District Hospital of Traditional Chinese Medicine,Tianjin 301700,China
关键词:
重症急性胰腺炎炎性反应营养支持
Keywords:
Severe acute pancreatitisInflammatory responseNutrition support
分类号:
R576
DOI:
10.3969/j.issn.1006-1959.2021.19.014
文献标志码:
A
摘要:
重症急性胰腺炎(SAP)是临床常见疾病,属于急性胰腺炎的特殊类型,累及多脏器,具有并发症多、发病急、病情进展快、病死率高的特点,故临床及时有效的治疗至关重要。目前,临床治疗SAP的方法较多,各有优劣势,且临床治疗疗效存在差异。如何科学合理选择治疗方法,改善患者预后是当前临床研究的重点。本文就SAP的内科和外科治疗方法作一综述,以期为临床选择治疗方法提供参考。
Abstract:
Severe acute pancreatitis (SAP) is a common clinical disease, belonging to the special type of acute pancreatitis, which involves multiple organs. At the same time, it has many complications, acute onset, rapid progress of disease, high mortality, so clinical timely and effective treatment is crucial. At present, there are many methods for clinical treatment of SAP with advantages and disadvantages, and there are differences in clinical therapeutic efficacy. How to choose the treatment method scientifically and reasonably and improve the prognosis of patients is the focus of current clinical research. This article reviews the medical and surgical treatment of SAP, in order to provide reference for clinical selection of treatment methods.

参考文献/References:

[1]张勇强,黄涛,尔启东.控制性液体复苏和单纯性液体复苏对重症急性胰腺炎患者治疗转归的影响[J].临床医学,2015,35(12):21-23.[2]姚红兵,曾荣城,文明波,等.早期肠内营养与延迟肠内营养治疗重症急性胰腺炎的临床疗效比较[J].实用医学杂志,2014,30(14):2231-2233.[3]倪俊,严强,袁文斌,等.肠内营养支持治疗时机选择对重症急性胰腺炎的作用[J].中华消化外科杂志,2015,14(5):390-394.[4]Zhang LH,Wang J,Sun GJ,et al.Effects of early enteral nutritionin patients with severe acute inflammatory cytokine levels andimmune function[J].J Hanan Med Coll,2015,21(6):758-761,765.[5]胡毅,博涛,高文彪.早期肠内营养支持对重症急性胰腺炎患者炎症反应和免疫功能的影响[J].中国老年学杂志,2015,35(8):2083-2084.[6]王晶,黎发海,侯建洪,等.鼻胃管和鼻空肠管应用于重症急性胰腺炎患者肠内营养治疗的效果分析[J].检验医学与临床,2018,15(15):2258-2261,2265.[7]许守明.早期肠内营养与延迟肠内营养对重症急性胰腺炎患者腹内高压及免疫功能的影响[J].中国全科医学,2016,19(14):1711-1714.[8]李科军,向正国,陈旭峰,等.早期大剂量乌司他丁联合奥曲肽治疗对重症急性胰腺炎患者炎症因子和T淋巴细胞的影响[J].海南医学院学报,2015,21(7):929-932.[9]陈霞,乔江蓉,孙巍.生长抑素联合艾司奥美拉唑治疗SAP的疗效观察[J].西南国防医药,2019,29(8):834-836.[10]孙娜.生长抑素、乌司他丁联合肠内营养在重症急性胰腺炎中的疗效分析[J].中国现代医生,2020,58(30):112-114,118.[11]Wang MJ,Ailin W,Qiang G,et al.Clinical outcomes of combined necrotizingpancreatitis versus extrapancreatic necrosis alone[J].Pancreatology,2016,1(16):161-164.[12]Greenberg JA,Hsu J,Bawazeer M,et al.Clinical practice guideline:management of acute pancreatitis[J].Can J Surg,2016,59(2):128-140.[13]满意,常加伟,汤亲青.重症急性胰腺炎不同病程的细菌移位及肠道菌群组成结构的变化研究[J].中国急救医学,2019,39(1):71-76.[14]Tian BN,He JH,Huang M.Effect of octretide and breviscapineon blood rheology and serum inflammatory factors in patients with severe acute pancreatitis[J].J Clin Med Pract,2015,19(17):38-40.[15]张鲲鹏.采用腹腔镜下腹腔灌洗引流术治疗重症胰腺炎的临床疗效分析[J].中国现代药物应用,2019,13(3):26-27.[16]刘勇帆,刘苏华,曾先涛.硫酸镁不同给药方式在重症急性胰腺炎中的应用疗效[J].世界华人消化杂志,2016,24(19):3045-3050.[17]沈红波,周一农,姜明,等.早期肠内营养加入微生态制剂对重症急性胰腺炎患者肠黏膜功能和炎症反应的影响[J].全科医学临床与教育,2019,17(10):912-915.[18]罗柳青.肠内营养在重症监护室重症胰腺炎患者中的应用效果[J].临床合理用药杂志,2017,10(24):58-59.[19]李丕宝,姚艳粉.内镜下腹腔置管灌洗治疗SAP合并IAH/ACS效果观察[J].山东医药,2017,57(21):93-95.[20]沈文娟,张琛.血液净化时生长抑素强化治疗对SAP转归的影响[J].中国继续医学教育,2019,11(26):107-109.[21]刘聪,袁方,李静云.持续性与间歇性血液净化治疗重症急性胰腺炎合并急性肾衰竭的效果比较[J].临床医学,2020,40(4):23-25.[22]张珂,单艳华.生长抑素联合持续血液净化对重症胰腺炎患者炎性因子及免疫功能的影响[J].黑龙江医药科学,2020,43(1):101-102,104.[23]徐静.柴芍承气汤联合生长抑素在重症急性胰腺炎治疗中的应用价值分析[J].中国医药指南,2016,14(11):203-204.[24]张海燕.柴芩承气汤治疗急性胰腺炎的临床疗效及安全性[J].临床合理用药杂志,2018,11(21):36-37. [25]翟超,刘晓晨,付伟,等.CT引导下经皮穿刺置管负压引流联合腹膜透析治疗重症胰腺炎[J].中华肝胆外科杂志,2015,21(5):317-320.[26]杜姗,卜爱.肠内营养治疗在重症监护室重症急性胰腺炎治疗中的临床研究[J].陕西医学杂志,2019,48(7):913-915.[27]雷达,李永利,祁军安.经皮穿刺置管引流 SAP合并胰腺坏死组织感染的临床效果分析[J].中华普外科手术学杂志,2016,10(6):497-500.[28]张杰.腹腔置管引流对重症急性胰腺炎的疗效观察[J].中国医师杂志,2015,16(10):1423-1424.

相似文献/References:

[1]盛海龙,方长太,查佳安.超声造影对重症急性胰腺炎并发早期急性肾损的诊断价值[J].医学信息,2022,35(09):171.[doi:10.3969/j.issn.1006-1959.2022.09.044]
 SHENG Hai-long,FANG Chang-tai,ZHA Jia-an.Diagnostic Value of Contrast-enhanced Ultrasonography in Severe Acute Pancreatitis Complicated with Early Acute Kidney Injury[J].Medical Information,2022,35(19):171.[doi:10.3969/j.issn.1006-1959.2022.09.044]
[2]车鹏博,阮继刚,郭 丹.红细胞分布宽度联合D-二聚体含量预测 急性胰腺炎严重程度的价值[J].医学信息,2018,31(12):73.[doi:10.3969/j.issn.1006-1959.2018.12.022]
 CHE Peng-bo,RUAN Ji-gang,GUO Dan.The Value of Red Blood Cell Distribution Width Combined with D-dimer Content in Predicting the Severity of Acute Pancreatitis[J].Medical Information,2018,31(19):73.[doi:10.3969/j.issn.1006-1959.2018.12.022]
[3]只茂叶.重症急性胰腺炎的发病机制与内镜治疗研究[J].医学信息,2022,35(11):68.[doi:10.3969/j.issn.1006-1959.2022.11.019]
 ZHI Mao-ye.The Pathogenesis and Endoscopic Treatment of Severe Acute Pancreatitis[J].Medical Information,2022,35(19):68.[doi:10.3969/j.issn.1006-1959.2022.11.019]
[4]陈艳玲.内镜下止血术联合奥曲肽治疗上消化道出血的临床效果[J].医学信息,2022,35(11):141.[doi:10.3969/j.issn.1006-1959.2022.11.037]
 CHEN Yan-ling.Clinical Effect of Endoscopic Hemostasis Combined with Octreotide in the Treatment of Upper Gastrointestinal Bleeding[J].Medical Information,2022,35(19):141.[doi:10.3969/j.issn.1006-1959.2022.11.037]
[5]杨 雍,吕汝琦,刘 丹.早期无创正压通气对重症急性胰腺炎合并肺损伤的保护作用机制[J].医学信息,2019,32(03):55.[doi:10.3969/j.issn.1006-1959.2019.03.018]
 YANG Yong,LV Ru-qi,LIU Dan.Protective Mechanism of Early Noninvasive Positive Pressure Ventilation on Severe Acute Pancreatitis Complicated with Lung Injury[J].Medical Information,2019,32(19):55.[doi:10.3969/j.issn.1006-1959.2019.03.018]
[6]刘 云,于洪波.乌司他丁与生长抑素治疗重症急性胰腺炎临床疗效观察[J].医学信息,2019,32(01):160.[doi:10.3969/j.issn.1006-1959.2019.01.050]
 LIU Yun,YU Hong-bo.Clinical Efficacy of Ulinastatin and Somatostatin in the Treatment of Severe Acute Pancreatitis[J].Medical Information,2019,32(19):160.[doi:10.3969/j.issn.1006-1959.2019.01.050]
[7]郭 磊,王小文,向小勇.中性粒细胞与淋巴细胞比值与肺癌预后关系研究[J].医学信息,2019,32(09):35.[doi:10.3969/j.issn.1006-1959.2019.09.012]
 GUO Lei,WANG Xiao-wen,XIANG Xiao-yong.Relationship between Neutrophil-lymphocyte Ratio and Prognosis of Lung Cancer[J].Medical Information,2019,32(19):35.[doi:10.3969/j.issn.1006-1959.2019.09.012]
[8]李 贺,付 锐,孙远松,等.早期区域动脉灌注肝素治疗高脂血症性SAP的临床效果[J].医学信息,2019,32(10):99.[doi:10.3969/j.issn.1006-1959.2019.10.031]
 LI He,FU Rui,SUN Yuan-song,et al.Clinical Effect of Early Regional Arterial Infusion of Heparin inthe Treatment of SAP with Hyperlipidemia[J].Medical Information,2019,32(19):99.[doi:10.3969/j.issn.1006-1959.2019.10.031]
[9]陈智华.赤芍加清胰汤联合空肠营养治疗重症急性胰腺炎的临床效果[J].医学信息,2019,32(21):156.[doi:10.3969/j.issn.1006-1959.2019.21.052]
 CHEN Zhi-hua.Clinical Observation on Treatment of Severe Acute Pancreatitis with Chishao Plus Qingyi Decoction Combined with Jejunal Nutrition[J].Medical Information,2019,32(19):156.[doi:10.3969/j.issn.1006-1959.2019.21.052]
[10]张 春,王锦姝,王寿宇,等.VSD治疗骨科软组织创伤及创面感染的临床效果分析[J].医学信息,2021,34(23):47.[doi:10.3969/j.issn.1006-1959.2021.23.013]
 ZHANG Chun,WANG Jin-shu,WANG Shou-yu,et al.Clinical Effect of VSD in the Treatment of Orthopedic Soft Tissue Trauma and Wound Infection[J].Medical Information,2021,34(19):47.[doi:10.3969/j.issn.1006-1959.2021.23.013]

更新日期/Last Update: 1900-01-01